Evidence map›Paper›PMID 10373507›Full record

ArticleMolecular and cellular biology1999

Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets.

N S Belaguli, W Zhou, T H Trinh, M W Majesky, R J Schwartz

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. O-GlcNAcylation inhibits hepatic stellate cell activation.Journal of gastroenterology and hepatology · 2021
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. RNA binding proteins in the regulation of heart development.The international journal of biochemistry & cell biology · 2013
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Embryological origin of airway smooth muscle.Proceedings of the American Thoracic Society · 2008
    Review
  18. Variety is the splice of life.Journal of molecular and cellular cardiology · 2008
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

N S BelaguliDepartments of Cell Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
W Zhou
T H Trinh
M W Majesky
R J Schwartz
Baylor College of Medicine · US

Funding

UNDERSTANDING OUTFLOW TRACT DEFECTS IN DIGEORGE SYNDROME--CHROMOSOME ENGINEERINGP01HL049953 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SCHNEIDER, MICHAEL J · 1993 to 2007
$16.3M
NHLBI NIH HHS P01 HL049953NHLBI NIH HHS P01HL49953
6 · The paper itself

Abstract

Primary transcripts encoding the MADS box superfamily of proteins, such as MEF2 in animals and ZEMa in plants, are alternatively spliced, producing several isoformic species. We show here that murine serum response factor (SRF) primary RNA transcripts are alternatively spliced at the fifth exon, deleting approximately one-third of the C-terminal activation domain. Among the different muscle types examined, visceral smooth muscles have a very low ratio of SRFDelta5 to SRF. Increased levels of SRFDelta5 correlates well with reduced smooth muscle contractile gene activity within the elastic aortic arch, suggesting important biological roles for differential expression of SRFDelta5 variant relative to wild-type SRF. SRFDelta5 forms DNA binding-competent homodimers and heterodimers. SRFDelta5 acts as a naturally occurring dominant negative regulatory mutant that blocks SRF-dependent skeletal alpha-actin, cardiac alpha-actin, smooth alpha-actin, SM22alpha, and SRF promoter-luciferase reporter activities. Expression of SRFDelta5 interferes with differentiation of myogenic C2C12 cells and the appearance of skeletal alpha-actin and myogenin mRNAs. SRFDelta5 repressed the serum-induced activity of the c-fos serum response element. SRFDelta5 fused to the yeast Gal4 DNA binding domain displayed low transcriptional activity, which was complemented by overexpression of the coactivator ATF6. These results indicate that the absence of exon 5 might be bypassed through recruitment of transcription factors that interact with extra-exon 5 regions in the transcriptional activating domain. The novel alternatively spliced isoform of SRF, SRFDelta5, may play an important regulatory role in modulating SRF-dependent gene expression.

Indexed as

Alternative SplicingSaccharomyces cerevisiae ProteinsTranscriptional Activation3T3 CellsActivating Transcription Factor 6AnimalsAortaBinding SitesCell DifferentiationCell LineChlorocebus aethiopsDimerizationDNA-Binding ProteinsExonsFungal ProteinsMiceActivating Transcription Factor 6Atf6 protein, mouseAtf6 protein, ratDNA-Binding ProteinsFungal ProteinsGAL4 protein, S cerevisiaeNuclear ProteinsProto-Oncogene Proteins c-fosRecombinant Fusion ProteinsSaccharomyces cerevisiae ProteinsSerum Response FactorTranscription Factors

Identifiers

PMID10373507
PMCPMC84256
OpenAlexW2097080468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.